CTG to Announce Second Quarter 2020 Financial Results on July 21
BUFFALO, N.Y., July 09, 2020 (GLOBE NEWSWIRE) — CTG (NASDAQ: CTG), a leading provider of information technology (IT) solutions and […]
Visteon to Announce Second-Quarter 2020 Results on Thursday, July 30
VAN BUREN TOWNSHIP, Mich., July 09, 2020 (GLOBE NEWSWIRE) — Visteon Corporation (Nasdaq: VC) plans to release its second-quarter 2020 […]
CENTOGENE Announces the Scientific Publication of a holistic solution in the preventive testing of COVID-19
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 09, 2020 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage diagnostics […]
Communication Service Providers Invest in Analytics and Traffic Optimization Systems for Better Connected Car and Subscriber Mobility Experiences
ST. LOUIS, July 09, 2020 (GLOBE NEWSWIRE) — Amdocs (NASDAQ: DOX), a leading provider of software and services to communications […]
TELA Bio Announces Interim Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair
MALVERN, Pa., July 09, 2020 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on designing, […]
Opera announces investment in and agreement to acquire Fjord Bank
OSLO, Norway, July 09, 2020 (GLOBE NEWSWIRE) — Opera Limited (Nasdaq: OPRA) (“Opera”) is one of the world’s leading browser […]
Yandex to Announce Second Quarter 2020 Financial Results on July 28th
MOSCOW and AMSTERDAM, July 09, 2020 (GLOBE NEWSWIRE) — Yandex (NASDAQ and MOEX: YNDX) today announced it will report its […]
Tesla Announces Date for Second Quarter 2020 Financial Results and Webcast
PALO ALTO, Calif., July 08, 2020 (GLOBE NEWSWIRE) — Tesla will post its financial results for the second quarter of […]
Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock
REDWOOD CITY, Calif., July 08, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq:RVMD) today announced the pricing of its underwritten […]
First Extensive Validation Study of Saphyr for Constitutional Genetic Disorders by European Consortium Shows 100% Concordance to Standard Cytogenetics and Describes Resolution of Cases of Long-Standing, Undiagnosed Disease
First large study in constitutional genetic diseases showed 100% concordance to gold-standard cytogenetic testingIn patients with leukemia, Saphyr enabled crucial […]
